Cargando…
Peptide Super-Agonist Enhances T-Cell Responses to Melanoma
Recent immunotherapeutic approaches using adoptive cell therapy, or checkpoint blockade, have demonstrated the powerful anti-cancer potential of CD8 cytotoxic T-lymphocytes (CTL). While these approaches have shown great promise, they are only effective in some patients with some cancers. The potenti...
Autores principales: | Galloway, Sarah A. E., Dolton, Garry, Attaf, Meriem, Wall, Aaron, Fuller, Anna, Rius, Cristina, Bianchi, Valentina, Theaker, Sarah, Lloyd, Angharad, Caillaud, Marine E., Svane, Inge Marie, Donia, Marco, Cole, David K., Szomolay, Barbara, Rizkallah, Pierre, Sewell, Andrew K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425991/ https://www.ncbi.nlm.nih.gov/pubmed/30930889 http://dx.doi.org/10.3389/fimmu.2019.00319 |
Ejemplares similares
-
Genome-wide CRISPR-Cas9 Screening Reveals Ubiquitous T cell Cancer
Targeting via the monomorphic MHC class I related protein MR1
por: Crowther, Michael D., et al.
Publicado: (2020) -
A Molecular Switch Abrogates Glycoprotein 100 (gp100) T-cell Receptor
(TCR) Targeting of a Human Melanoma Antigen
por: Bianchi, Valentina, et al.
Publicado: (2016) -
Peptide–MHC Class I Tetramers Can Fail To Detect Relevant Functional T Cell Clonotypes and Underestimate Antigen-Reactive T Cell Populations
por: Rius, Cristina, et al.
Publicado: (2018) -
T-cell libraries allow simple parallel generation of multiple peptide-specific human T-cell clones
por: Theaker, Sarah M., et al.
Publicado: (2016) -
Optimized Peptide–MHC Multimer Protocols for Detection and Isolation of Autoimmune T-Cells
por: Dolton, Garry, et al.
Publicado: (2018)